Maria Groves is the laboratory head of the innovative Cancer Research UK (CRUK) – MedImmune Alliance Laboratory with a multi-disciplinary team of scientists from both CRUK and MedImmune at a CRUK funded facility. The laboratory utilises Medimmune’s antibody discovery protein engineering capabilities to discover new medicines for the treatment
of cancer. This innovative alliance works with the oncology principaI investigator (PI) network throughout the UK and is now extending interactions into Europe. Maria leads the Alliance team to work with selected PI’s on projects to generate novel antibody diagnostics and therapeutics for cancer therapy. Maria is an industry recognised expert
and leader in the field of ribosome display and protein engineering. She joined the company (Cambridge Antibody Technology/MedImmune Ltd.)
in 2000 and established herself as a recognised scientific expert in ribosome display. She continued to broaden her skill base to include antibody phage display and engineering, and hybridoma technology. As a project leader, she has also successfully led antibody therapeutics from research phase into clinical trials.